NCT00712686View on ClinicalTrials.gov

Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

690

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Schizophrenia
Interventions
DRUG

Aripiprazole

Tablets, Oral, 15-30 mg, once daily, 140 weeks

DRUG

Olanzapine

Capsule, Oral, 10-20 mg, once daily, 140 weeks

All Listed Sponsors
lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT00712686 - Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute Schizophrenia | Biotech Hunter | Biotech Hunter